ScholarLens Back to search
2010•Journal of Medical ForumRequires access

Effect of Budesonide/Formoterol Inhaling Treatment on Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Xin Ding

Open publisher page 0 citations

Abstract

Objective To investigate the effect of budesonide/formoterol fumarate powder for inhalation treatment on the acute exacerbations of chronic obstructive pulmonary disease (AECOPD).Methods Totally 98 subjects with AECOPD were divided into two groups randomly.Baseline treatment was equal in all patient.On the base of routine therapy of control group (49 cases),the trial group (49 cases) received budesonide/formoterol (160μg/4.5μg) inhalation twice a day additionally.Compare the difference of two groups at FEV1,FEV1%,FEV1/FVC and the scores of SGRQ before and after the therapy.Results The FEV1,FEV1%,FEV1/FVC and the scores of SGRQ in both groups were improved in evidence (P0.05),and the trial group were better than the control group (P0.05).Conclusion Budesonide/formoterol fumarate powder for inhalation can improve the pulmonary function and quality of life of the AECOPD patients and should be popularized as an effective method.

About this research paper

What this paper is about

Objective To investigate the effect of budesonide/formoterol fumarate powder for inhalation treatment on the acute exacerbations of chronic obstructive pulmonary disease (AECOPD).Methods Totally 98 subjects with AECOPD were divided into two groups randomly.Baseline treatment was equal in all patient.On the base of routine therapy of control group (49 cases),the trial group (49 cases) received budesonide/formoterol (160μg/4.5μg) inhalation twice a day additionally.Compare the difference of two groups at FEV1,FEV1%,FEV1/FVC and the scores of SGRQ before and after the therapy.Results The FEV1,FEV1%,FEV1/FVC and the scores of SGRQ in both groups were improved in evidence (P0.05),and the trial group were better than the control group (P0.05).Conclusion Budesonide/formoterol fumarate powder for inhalation can improve the pulmonary function and quality of life of the AECOPD patients and should be popularized as an effective method.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of budesonide/formoterol fumarate powder for inhalation treatment on the acute exacerbations of chronic obstructive pulmonary disease (AECOPD).Methods Totally 98 subjects with AECOPD were divided into two groups randomly.Baseline treatment was equal in all patient.On the base of routine therapy of control group (49 cases),the trial group (49 cases) received budesonide/formoterol (160μg/4.5μg) inhalation twice a day additionally.Compare the difference of two groups at FEV1,FEV1%,FEV1/FVC and the scores of SGRQ before and after the therapy.Results The FEV1,FEV1%,FEV1/FVC and the scores of SGRQ in both groups were improved in evidence (P0.05),and the trial group were better than the control group (P0.05).Conclusion Budesonide/formoterol fumarate powder for inhalation can improve the pulmonary function and quality of life of the AECOPD patients and should be popularized as an effective method.

Key concepts: Budesonide, Formoterol, Medicine, Inhalation, Pulmonary disease, Budesonide/formoterol, Pulmonary function testing, Anesthesia

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Effect of Budesonide/Formoterol Inhaling Treatment on Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Research Paper | ScholarLens